123 related articles for article (PubMed ID: 3967579)
1. A third class of drugs: an overview.
Brushwood DB; Abood RR
Drug Intell Clin Pharm; 1985 Jan; 19(1):62-6. PubMed ID: 3967579
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing pharmacists' preference for the legal classification of Rx-to-OTC switched drug products.
Madhaven S
J Clin Pharm Ther; 1993 Aug; 18(4):281-90. PubMed ID: 8227236
[TBL] [Abstract][Full Text] [Related]
3. Prescription to over-the-counter switch: a regulatory perspective.
Juhl RP
Clin Ther; 1998; 20 Suppl C():C111-7. PubMed ID: 9915097
[TBL] [Abstract][Full Text] [Related]
4. Report of the Task Force on the future of OTC drugs.
Collins DE
Food Drug Law J; 2000; 55(1):27-31. PubMed ID: 12269359
[No Abstract] [Full Text] [Related]
5. Evolution of self-care with over-the-counter medications.
Soller RW
Clin Ther; 1998; 20 Suppl C():C134-40. PubMed ID: 9915100
[TBL] [Abstract][Full Text] [Related]
6. Prescription to over-the-counter drug reclassification.
Jacobs LR
Am Fam Physician; 1998 May; 57(9):2209-14. PubMed ID: 9606310
[TBL] [Abstract][Full Text] [Related]
7. Plan BTC: the case for a third class of drugs in the United States.
Healey D
Food Drug Law J; 2008; 63(1):375-89. PubMed ID: 18561465
[No Abstract] [Full Text] [Related]
8. Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly?
Francis SA; Barnett N; Denham M
Drugs Aging; 2005; 22(5):361-70. PubMed ID: 15903349
[TBL] [Abstract][Full Text] [Related]
9. Regulation of topical antimicrobials: history, status and future perspective.
Bruch MK; Larson E
Infect Control Hosp Epidemiol; 1989 Nov; 10(11):505-8. PubMed ID: 2685100
[TBL] [Abstract][Full Text] [Related]
10. New OTC drugs and devices 1999: a selective review.
Newton GD; McCullough JA; Pray WS; Popovich NG
J Am Pharm Assoc (Wash); 2000; 40(2):222-33. PubMed ID: 10730023
[TBL] [Abstract][Full Text] [Related]
11. Is a third class of drugs in pharmacy's future?
Martin S
Am Pharm; 1991 Apr; NS31(4):36-40. PubMed ID: 2038961
[No Abstract] [Full Text] [Related]
12. The drug regulatory system: reflections and predictions.
Crout JR
Drug Intell Clin Pharm; 1981 Oct; 15(10):793-8. PubMed ID: 7285799
[No Abstract] [Full Text] [Related]
13. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
[No Abstract] [Full Text] [Related]
14. Prescription Requirements and Patient Autonomy: Considering an Over-the-Counter Default.
Kilbride M; Joffe S; Lynch HF
Hastings Cent Rep; 2020 Nov; 50(6):15-26. PubMed ID: 33315251
[TBL] [Abstract][Full Text] [Related]
15. Direct-to-OTC marketing of drugs: possible approaches.
Mahinka SP; Bierman ME
Food Drug Law J; 1995; 50(1):49-63. PubMed ID: 10342985
[No Abstract] [Full Text] [Related]
16. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
Spencer HM
Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
[No Abstract] [Full Text] [Related]
17. New OTC drugs and devices 1997: a selective review.
Newton GD; Pray WS; Popovich NG
J Am Pharm Assoc (Wash); 1998; 38(2):199-209. PubMed ID: 9654848
[TBL] [Abstract][Full Text] [Related]
18. Steps taken to lessen tampering with OTC drugs.
FDA Drug Bull; 1983 Apr; 13(1):6. PubMed ID: 6852409
[No Abstract] [Full Text] [Related]
19. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
[TBL] [Abstract][Full Text] [Related]
20. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(74):18869-82. PubMed ID: 12701600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
